skip to main content
Idioma:
Refinado por: Nome da Publicação: Aids remover assunto: Middle Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease
Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease

BORGES, Alvaro H ; LUNDGREN, Jens D ; GARGALIANOS, Panagiotis ; MOCROFT, Amanda ; RIDOLFO, Annalisa ; KATLAMA, Christine ; ANTUNES, Francisco ; GRZESZCZUK, Anna ; BLAXHULT, Anders ; MITSURA, Viktar M ; DOROANA, Manuela ; BATTEGAY, Manuel

AIDS (London), 2014-11, Vol.28 (17), p.2565-2571 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
2
Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials
Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials

KATLAMA, Christine ; HAUBRICH, Richard ; WOODFALL, Brian ; DE SMEDT, Goedele ; LALEZARI, Jacob ; LAZZARIN, Adriano ; MADRUGA, José V ; MOLINA, Jean-Michel ; SCHECHTER, Mauro ; PEETERS, Monika ; PICCHIO, Gaston ; VINGERHOETS, Johan

AIDS (London), 2009-11, Vol.23 (17), p.2289-2300 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
3
A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients
A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients

VAN LEEUWEN, Remko ; KATLAMA, Christine ; MORONI, Mauro ; PAVIA, Andrew T ; SCHMIDT, Reinhold E ; GONZALEZ-LAHOZ, Juan ; MONTANER, Julio ; ANTUNES, Francisco ; GULICK, Robert ; BANHEGYI, Dénes ; VAN DER VALK, Marc ; REISS, Peter ; MURPHY, Robert L ; VAN WEERT, Liesbeth ; VAN LETH, Frank ; JOHNSON, Victoria A ; SOMMADOSSI, Jean-Pierre ; LANGE, Joep M. A ; SQUIRES, Kathleen ; GATELL, José ; HORBAN, Andrej ; CLOTET, Bonaventura ; STASZEWSKI, Shlomo ; VAN EEDEN, Arne ; CLUMECK, Nathan

AIDS (London), 2003-05, Vol.17 (7), p.987-999 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
4
Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients
Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients

PETERS, Lars ; GRINT, Daniel ; LUNDGREN, Jens D ; ROCKSTROH, Jürgen K ; SORIANO, Vincent ; REISS, Peter ; GRZESZCZUK, Anna ; SAMBATAKOU, Helen ; MOCROFT, Amanda ; KIRK, Ole

AIDS (London), 2012-09, Vol.26 (15), p.1917-1926 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
5
Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy
Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy

KOWALSKA, Justyna D ; REEKIE, Joanne ; MOCROFT, Amanda ; REISS, Peter ; LEDERGERBER, Bruno ; GATELL, Jose ; D'ARMINIO MONFORTE, Antonella ; PHILLIPS, Andrew ; LUNDGREN, Jens D ; KIRK, Ole

AIDS (London), 2012-01, Vol.26 (3), p.315-323 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
6
Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA
Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA

BANNISTER, Wendy P ; RUIZ, Lidia ; LUNDGREN, Jens D ; COZZI-LEPRI, Alessandro ; MOCROFT, Amanda ; KIRK, Ole ; STASZEWSKI, Schlomo ; LOVEDAY, Clive ; KARLSSON, Anders ; D'ARMINIO MONFORTE, Antonella ; CLOTET, Bonaventura

AIDS (London), 2008-01, Vol.22 (3), p.367-376 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
7
Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?
Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?

REEKIE, Joanne ; MOCROFT, Amanda ; SAMBATAKOU, Helen ; MACHALA, Ladislav ; CHIESI, Antonio ; VAN LUNZEN, Jan ; CLUMECK, Nathan ; KIRK, Ole ; GAZZARD, Brian ; LUNDGREN, Jens D

AIDS (London), 2008-11, Vol.22 (17), p.2381-2390 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
8
A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study Team
A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study Team
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study Team

Haubrich, R ; Thompson, M ; Schooley, R ; Lang, W ; Stein, A ; Sereni, D ; van der Ende, M E ; Antunes, F ; Richman, D ; Pagano, G ; Kahl, L ; Fetter, A ; Brown, D J ; Clumeck, N

AIDS (London), 1999-12, Vol.13 (17), p.2411 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.